Plymouth, MN – January 14, 2016 – Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog – 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience
Visitors to catalog.mcpur.com will find a built-in search function giving the user a tool to find specific products quickly. “We are excited to release this new interactive tool to our customers and hope that it makes their research and procurement of dialysis water products a more efficient and enjoyable process.” – Chris Fournier, VP Marketing. Some of the benefits provided by the digital catalog include:
- Full color catalog with products specific to Dialysis Water
- Easily navigate and search for products
- Drilldown navigation to specific products/product categories
- Product or keyword search
- Ability to add products to a cart and request part number specific quotes that get emailed directly to Customer Service
- Cross platform functionality with mobile responsive navigation
“The intent of the project was two-fold. First, as the largest provider of hemodialysis water equipment in North America, we wanted to have a catalog that provided products specific to those hemodialysis water users and providers. Second, we wanted to improve the experience of finding product and pricing information by presenting a more interactive and easy to use tool” said Chris Fournier, VP Marketing.
Hard copies of the new Dialysis Water Product Catalog can be requested by by calling Mar Cor Customer Service at 800.633.3080. Visit catalog.mcpur.com today to check out the all new Mar Cor Purification Dialysis Water Digital Catalog, and keep up-to-date with exiting new dialysis products and services designed to ensure safe water and improve provider productivity.
About Cantel Medical
Cantel Medical (NYS: CMN) – Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com .
About Mar Cor Purification
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network. Visit our website at mcpur.com to find out more about Mar Cor Purification.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel’s filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification.